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Abstract: The screening of the most convenient mobile phase composition is presented for the chiral 
separation of the four stereoisomers of the -blocker drug nadolol. When the final goal is the 
preparative chiral separation, this selection is critical, since solubility, selectivity and retention are all 
parameters very sensitive with mobile phase composition. Experimental results will show that the 
 !"#$%& '(!)*"& +,-#"& .('+(#)$)(/& )#0& 1"/"2-**30& 4"23& 5)66"2"/$& if we consider an analytical or a 
preparative separation point of view. 
 
Nadolol, 5 - {3 - [(1,1 - dimethylethyl)amino] - 2 - hydroxypropoxy} - 1,2,3,4 -  tetrahydro - cis - 2,3-
naphtalenediol is a beta-adrenergic receptor antagonist ( -blocker) drug, widely used in the treatment 
of hypertension, ischemic heart disease (angina pectoris), congestive heart failure and certain 
arrhythmias (Brunton el al., 2001). Its chemical structure has three stereogenic centers which allows 
for eight possible stereoisomers (McCarthy, 1994). However, the two hydroxyl substituents on the 
cyclohexane ring are fixed in the cis-configuration which precludes four stereoisomers. This drug is 
currently marketed as an equal mixture of four stereoisomers (see Fig. 1). Separation and isolation of 
each of the four stereoisomers is necessary, in order to study its pharmacological and therapeutic 
behaviour as single enantiomer. In the case of nadolol, and for a safe and more effective use, it is 
better to separate the most active enantiomer (RSR)-nadolol before use (X. Wang and C. Ching, 2003). 
 
Today, preparative chiral chromatography has become an attractive technology, used to obtain single 
enantiomeric drugs, in the biotechnology, fine chemical products and pharmaceutical industries. The 
chiral separation process is a complex task, governed by several different interactions between the 
chiral solutes, the solvent and the chiral stationary phase. In a preparative point of view, and when 
considering the choice of the mobile phase (solvent) composition, a high selectivity of the enantiomers 
should not be the only goal to be aimed, as it is frequently followed at analytical scale. In this choice, a 
high solubility and low retention time should also be taken into account, in order to improve the 
preparative process performance (Ribeiro et al., 2008 and 2009). 
 
Experimental results obtained for the separation of nadolol stereoisomers include a detailed screening 
of different mobile phase compositions using a Chiralpak® AD stationary phase. The choice of the 
 !"#$%&.('+(#)$)(/&)#&+"26(2'"5&)/&$"2'#&(6&(21-/).&'(5)6)"2 (diethylamine, DEA), alcoholic content 
(different alcohols) in a traditional hydrocarbon solvent (different alkanes). The final conclusion for 
the mobile phase composition selection will be presented with the main goal of the preparative 
separation of nadolol stereoisomers.  
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Figure 1. Chemical structures of the four stereoisomers of nadolol. 
 
 
  
Figure 2. Effect of the ethanol content in an n-hexane mobile phase composition (with 0.3%DEA) on the 
capacity factor (left) and selectivity (right). 
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